Atea Pharmaceuticals to Host Virtual HCV KOL Panel Event on November 13, 2025

BOSTON, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that it will host a virtual key opinion leader (KOL) event on Thursday, November 13, 2025 at 10:00 AM ET to discuss a wide range of hepatitis C virus (HCV)-related topics including the current HCV patient population, the importance of early diagnosis ...